Instituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (77)

2024

  1. Accelerating SARS-CoV-2 genomic surveillance in a routine clinical setting with nanopore sequencing

    International Journal of Medical Microbiology, Vol. 314

  2. Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study

    The Lancet Regional Health - Europe, Vol. 41

  3. Impact of the Mediterranean Diet on the Gut Microbiome of a Well-Defined Cohort of Healthy Individuals

    Nutrients, Vol. 16, Núm. 6

  4. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM

    Intensive Care Medicine, Vol. 50, Núm. 4, pp. 502-515

  5. Microevolution, reinfection and highly complex genomic diversity in patients with sequential isolates of Mycobacterium abscessus

    Nature Communications, Vol. 15, Núm. 1

  6. Mining genomic repositories to further our knowledge of the extent of SARS-CoV-2 co-infections

    Microbial genomics, Vol. 10, Núm. 1

  7. Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study

    Mycoses, Vol. 67, Núm. 1

  8. No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir

    Journal of Medical Virology

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  2. Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  3. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  4. Frequent Emergence of Resistance Mutations Following Complex Intra-Host Genomic Dynamics in SARS-CoV-2 Patients Receiving Sotrovimab

    Antimicrobial agents and chemotherapy, Vol. 67, Núm. 7, pp. e0026623

  5. Microbiome profile and calprotectin levels as markers of risk of recurrent Clostridioides difficile infection

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  6. Non-nosocomial Healthcare-Associated Infective Endocarditis: A Distinct Entity? Data from the GAMES Series (2008-2021)

    Open Forum Infectious Diseases, Vol. 10, Núm. 8

  7. Reporting antimicrobial susceptibilities and phenotypes of resistance to vancomycin in vancomycin-resistant Enterococcus spp. clinical isolates: A nationwide proficiency study

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 6, pp. 335-341

2022

  1. Abiotrophia spp. and Granulicatella spp. Infective Endocarditis: A Contemporary Perspective

    Frontiers in bioscience (Elite edition), Vol. 14, Núm. 3, pp. 23

  2. Air pollution and health prevention: A document of reflection

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 307-332

  3. Bartonella Endocarditis in Spain: Case Reports of 21 Cases

    Pathogens, Vol. 11, Núm. 5

  4. Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 3, pp. 279-283

  5. Herpes zoster complicated with aseptic meningitis after cardiac transplantation: Report of two cases and review of the literature

    Revista Espanola de Quimioterapia